SYRE

Conviction 100HealthcareScan · Thu, Jun 25, 2026

SYRE$88.60+2.74%

ResistanceSupportVol 14

Vol MA14 1.88M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Spyre Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.spyre.com ↗

Price88.60

Change+2.74%

Gap+0.42%

Rel volume2.05×

Avg volume1.62M

Avg $ vol135.98M

SMA 2080.55

SMA 5075.57

SMA 20042.41

Price vs 50+17.24%

Price vs 200+108.90%

MA stackbullish

50/200 cross—

Supertrendup · 81.95

RSI (14)59

MACD hist0.91

MACD crossbull · 9d

Stoch %K / %D57 / 64

ADX (14)32

+DI / −DI31 / 21

RSI divergence—

MACD divergence—

ATR %+6.57%

ADR %5.95%

52w high100.32

52w low14.82

From 52w high-11.68%

Above 52w low+497.84%

New 52w highNo

SqueezeOff

Bollinger width42.41%

%B0.74

Donchian pos59.89%

Donchian high102.06

Donchian low68.50

AVWAP (52w high)89.70

vs AVWAP high-1.23%

AVWAP (52w low)44.66

vs AVWAP low+98.38%

OBV trendUp

Chaikin MF (20)0.13

Today vs 20d2.05×

Avg vol (14d)1.88M

Avg vol (20d)1.62M

Avg $ vol (20d)135.98M

Market cap7.69B

RS 3m (vs SPY)+92.01%

RS 6m (vs SPY)+150.47%

RS line new highNo

Trend template8/8

Technical rank90.4

1 week+1.27%

1 month+20.30%

3 months+93.96%

6 months+159.06%

1 year+474.95%

YTD+189.73%

P/E-49.57

P/B11.47

P/S—

P/FCF-45.46

EPS-49.12

Div yield—

ROE-23.14%

ROA-20.32%

Debt/Eq—

Current8.97

EV/EBITDA-36.25

Gross margin—

Net margin—

Rev growth—

EPS growth25.39%

Price target101.50

Target upside14.56%

Analyst ratingBuy

Institutional100.02%

Ent. value7.6B

Revenue0

Net income-69M

Gross profit—

Free cash flow-169.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out86.84M

Employees112

ListedThu, Apr 7, 2016

Free float66.88M

Float %85.2%

Short interest12.63M

Days to cover15.5d

Short volume54.6%

Squeeze score87 / 100

Next earningsTue, Aug 4, 2026 (40d)

EPS forecast−$0.71 · 4 est

Last EPS vs est−$0.74 vs −$0.66

Last surprise-12.1% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank90.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance90.80

Support65.93

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SYRE

All disclosures →

No recent disclosed trades by Congress in SYRE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SYRE

No recent insider (Form 4) filings in SYRE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SYRE · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.